Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120596_aabtl_02.txt-- All suspended atropine stocks are still awaiting FDA decision on shelf- life extension vs disposal. However, DPSC has advised us that they have replacement stock immediately available if required, - Current USAF worldwide stocks of drugs for CW/BW defense should be sufficient for any reasonable contingency since the worldwide requirements are based on a "base case" rather than a regional scenario. RECOMMENDATION None. For Information only.
Document Page: First | Prev | Next | All | Image | This Release | Search